-transparent.png){kind=logo}
In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa. 1994
University of New Mexico Medical Center, Albuquerque 87106.
Susceptibility tests were performed on 2402 of consecutive isolates of Enterobacteriaceae and 254 strains of Pseudomonas aeruginosa in five separate medical centres. Five beta-lactams were evaluated with and without a beta-lactamase inhibitor. The effect of different inhibitors was species specific and the rank order of decreasing efficacy against all enteric bacilli was: cefoperazone-sulbactam > piperacillin-tazobactam > cefoperazone > ticarcillin-clavulanic acid > piperacillin > co-amoxiclav > ampicillin-sulbactam > ticarcillin > ampicillin > amoxycillin.
Related Publications
J C McLaughlin, and
A L Barry, and
P C Fuchs, and
E H Gerlach, and
D J Hardy, and
M A Pfaller
June 2012,
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
J C McLaughlin, and
A L Barry, and
P C Fuchs, and
E H Gerlach, and
D J Hardy, and
M A Pfaller
September 2000,
Pharmacotherapy,
J C McLaughlin, and
A L Barry, and
P C Fuchs, and
E H Gerlach, and
D J Hardy, and
M A Pfaller
September 2010,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
J C McLaughlin, and
A L Barry, and
P C Fuchs, and
E H Gerlach, and
D J Hardy, and
M A Pfaller
November 2005,
The Indian journal of medical research,
J C McLaughlin, and
A L Barry, and
P C Fuchs, and
E H Gerlach, and
D J Hardy, and
M A Pfaller
April 2023,
International journal of antimicrobial agents,
J C McLaughlin, and
A L Barry, and
P C Fuchs, and
E H Gerlach, and
D J Hardy, and
M A Pfaller
April 2024,
Microbiology spectrum,
J C McLaughlin, and
A L Barry, and
P C Fuchs, and
E H Gerlach, and
D J Hardy, and
M A Pfaller
November 1982,
La Nouvelle presse medicale,
J C McLaughlin, and
A L Barry, and
P C Fuchs, and
E H Gerlach, and
D J Hardy, and
M A Pfaller
May 2021,
Antimicrobial agents and chemotherapy,
J C McLaughlin, and
A L Barry, and
P C Fuchs, and
E H Gerlach, and
D J Hardy, and
M A Pfaller
December 2023,
The Journal of antimicrobial chemotherapy,
J C McLaughlin, and
A L Barry, and
P C Fuchs, and
E H Gerlach, and
D J Hardy, and
M A Pfaller
September 2023,
ACS infectious diseases,
